Your browser doesn't support javascript.
loading
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study.
Trnený, Marek; Avigdor, Abraham; McKinney, Matthew S; Paneesha, Shankara; Wahlin, Björn E; Hrom, John S; Cunningham, David; Morley, Nicholas; Canales, Miguel; Bastos-Oreiro, Mariana; Belada, David; Devizzi, Liliana; Zheng, Fred; DeMarini, Douglas J; Jiang, Wei; Jiang, Ping; Lynch, Ryan C.
Affiliation
  • Trnený M; First Department of Medicine - Hematology, Charles University General Hospital, Prague, Czech Republic.
  • Avigdor A; Institute of Hematology, Sheba Medical Center, Ramat Gan, Israel.
  • McKinney MS; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Paneesha S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke Cancer Institute, Durham, NC, USA.
  • Wahlin BE; Department of Haematology & Stem Cell Transplantation, Birmingham Heartlands Hospital, Birmingham, UK.
  • Hrom JS; Karolinska Institutet, Department of Medicine, Huddinge, and Karolinska University Hospital, Unit for Hematology, Stockholm, Sweden.
  • Cunningham D; Forrest General Hospital and Hattiesburg Clinic of Hematology and Oncology, Hattiesburg, MS, USA.
  • Morley N; Royal Marsden Hospital, NHS Foundation Trust, London and Surrey, UK.
  • Canales M; Sheffield Teaching Hospital, NHS Foundation Trust, Sheffield and London, UK.
  • Bastos-Oreiro M; Hospital Universitario La Paz, Madrid, Spain.
  • Belada D; Hematology Department, Hospital General Universitario Gregorio Marañón (IiSGM), Madrid, Spain.
  • Devizzi L; Fourth Department of Internal Medicine - Hematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Zheng F; Division of Hemathology and Stem Cell Transplantation, IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • DeMarini DJ; Incyte Corporation, Wilmington, DE, USA.
  • Jiang W; Incyte Corporation, Wilmington, DE, USA.
  • Jiang P; Incyte Corporation, Wilmington, DE, USA.
  • Lynch RC; Incyte Corporation, Wilmington, DE, USA.
EClinicalMedicine ; 63: 102130, 2023 Sep.
Article de En | MEDLINE | ID: mdl-37662520
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EClinicalMedicine Année: 2023 Type de document: Article Pays d'affiliation: République tchèque
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: EClinicalMedicine Année: 2023 Type de document: Article Pays d'affiliation: République tchèque